Former Medicines Australia chair and senior Pfizer executive John Young sat down with BioPharmaDispatch following confirmation of his appointment to the health technology assessment review reference committee.
John Young expects open engagement and a focus on what patients want from HTA
October 28, 2022 Latest NewsBioPharmaBioPharmaDispatch ExecutiveLatest Video
New Stories
-
Stoking 'good' antibodies key to reducing serious bee venom allergic reactions
January 20, 2025 - - Australian Biotech -
'This is a world-leading approach to reduce the impact of RSV on babies'
January 20, 2025 - - Latest News -
New leadership for Boehringer Ingelheim as the company recognised as top employer
January 20, 2025 - - Latest News -
Christopher Luxon replaces health minister in push for faster progress on change
January 20, 2025 - - Latest News -
Make the institution and its nobility work for patients, not the other way around
January 16, 2025 - - Latest News -
Could this system's 'nobility' embrace a new idea, even if they recognised it?
January 15, 2025 - - Latest News -
Patients do not live their condition as aggregated economic models
January 14, 2025 - - Latest News